ELISA – Products

Lonza launched PyroCell® MAT Rapid System and PyroCell® MAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems containing the new PeliKine Human IL-6 Rapid ELISA Kit.

This whitepaper explores how to track HCPs of concern through purification steps, develop robust removal strategies and increase the HCP population coverage achieved.

BioPharmaSpec's HCP-MS Hub is an online resource which gathers together in-depth knowledge from expert scientists to help you further understand and implement LC-MS as part of your Host Cell Protein detection strategy.

Engaging in research is like participating in a high-stakes poker match. The potential reward? The discovery of the next blockbuster drug. The gamble? Risking billions on a molecule that doesn't pay off. In this game, the winning hand lies in the tools that can identify the most promising leads.

Range of highly selective anti-idiotypic antibodies now includes six antibodies specific to dupilumab and its biosimilars for bioanalysis and Drug Monitoring.

Sino Biological has accumulated rich experience in the development and production of custom antibodies, providing high-quality antibody production services for pharmaceutical enterprises, research institutions, and diagnostic companies, supporting basic research, diagnostic reagent development, biological drug development, and other applications.

Absolute Biotech has announced the reintroduction of SCICONS™ dsRNA antibodies, used to detect dsRNA intermediates of a wide range of viruses, including chikungunya, dengue, hepatitis, rabies, rhinovirus, polio and swine fever.

This whitepaper highlights the recent developments and performance of three modular benchtop solutions for the high-performance quantitation and kinetics characterization of proteins and their small molecule interactions.

As a global leader in the recombinant technology, Sino Biological provides a diverse array of recombinant proteins, antibodies, and ELISA kits to facilitate research and development of cancer treatments that focus on c-Kit and other RTKs (EGFR, VEGFR, PDGFR, c-Met, TrkB, FGFR, and more).

A new study has shown graphene-based biosensors could play a major role in detecting Interleukin-10 (IL-10), an important inflammation regulator, at significantly lower levels than previous point-of-care measurements.